Professor Peter Doshi: Pfizer and Moderna trial data raise serious concern over mRNA vaccine safety

by time news

Peter Doshi, professor of pharmacology at the University of Maryland(USA) and editor of the authoritative medical journal British Medical Journa, believes there is serious concern about the safety of mRNA vaccines, especially in people whose risk of Covid-19 is low.

He says this in an interview with the German television channel Central German Broadcasting (MDR) following his recently published analysis of the original Pfizer and Moderna trial data (1).

After a thorough analysis, a team of doctors and scientists, of which he was a part, calculated that the additional risk of a serious side effect in the trials from the mRNA vaccines was one in 800, while the prevention of hospitalizations due to the virus was about one in 5,000. was at Pfizer and one in 1,700 at Moderna. This means that the increase in serious side effects from the vaccines was greater than the reduction in COVID-related hospitalizations.

No American television channel was interested in interviewing him about this, nor were the major American newspapers.

To put the number of one in 800 vaccinees with a serious side effect during the trials into perspective, Doshi states that with other vaccines, this was one or two cases per million vaccinated.

“This number has taken vaccines off the market in the past.”

When asked, Doshi sees no justification for mandatory vaccination, for example for certain professions, mainly on the basis of the lack of convincing data that the vaccines reduce the transmission of the virus and stop epidemics. He also strongly advocates the release of the original trial data, from which the risks and benefits of the vaccines can be calculated much more accurately.

Doshi thinks that for an increasingly smaller population group, the benefits of the vaccines outweigh the risks, especially with the current, mild virus variants, and that the vaccines are hardly suitable for preventing infections.

The full interview can be viewed here, with Dutch subtitles:

The original German broadcast can be viewed here.

Reference:

  1. Fraiman J, Erviti J, Jones M, Greenland S, Whelan P, Kaplan RM, Doshi P. Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adults. Vaccine. 2022 Sep 22;40(40):5798-5805. doi: 10.1016/j.vaccine.2022.08.036. Epub 2022 Aug 31. PMID: 36055877; PMCID: PMC9428332.

Support us, become a friend!
Together we stand stronger. From fear back to confidence!

Disclaimer: The Doctors Collective is not responsible for the content on the mentioned pages of external parties to which reference is made. Sharing a page does not mean that the Doctors Collective shares all views. The Doctors Collective supports the gathering and sharing of (medical) information without censorship in order to stimulate an open conversation / scientific discussion.

You may also like

Leave a Comment